• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 354
  • 277
  • 33
  • 28
  • 18
  • 9
  • 8
  • 6
  • 6
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • Tagged with
  • 854
  • 854
  • 243
  • 94
  • 80
  • 79
  • 69
  • 69
  • 59
  • 55
  • 53
  • 53
  • 52
  • 51
  • 48
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.

Immune cell activity during cutaneous wound repair

Agaiby, Atif Devias January 1998 (has links)
No description available.

Activities of neurokinins and kinins in the skin microvasculature

Cao, Thong January 2001 (has links)
No description available.

The role of Pax6 in corneal development and maintenance

Dorà, Natalie January 2009 (has links)
<i>PAX77<sup>+</sup></i> mice were shown to express about 150% of wild-type Pax6 levels of corneal epithelial Pax6 and displayed abnormally small corneas due to a failure of postnatal growth and development of the cornea.  The proliferative component of the corneal epithelium was normal, cell cycle progression appears unaffected and there are no abnormal apoptotic events.  Cytokeratin-12 expression was down regulated in the <i>PAX77<sup>+ </sup></i>corneal epithelia, implying differentiation is incomplete, and the corneas of <i>PAX77<sup>+</sup></i> were found to display increased fragility in comparison to wild-types. <i>PAX77<sup>+</sup></i> corneas displayed sever wound healing abnormalities which in contrast to Pax6<sup>+/- </sup>can not be rescued by EGF addition.  Both <i>Pax6<sup>+/-</sup></i> and <i>PAX77<sup>+</sup> </i>corneal epithelia show no improvement in wound healing with addition of Shh peptide or all-trans retinoic acid (in contrast to wild-type), however in the <i>PAX77<sup>+</sup> </i>wound healing abnormalities do not lead to corneal opacity which is seen in <i>Pax6<sup>+/-</sup></i>.  Both <i>Pax6<sup>+/-</sup></i> and <i>PAX77<sup>+</sup></i>corneal epithelia have increased basal levels of retinoic acid signalling in their corneal epithelium when compared to wild-type littermates.  Topical application of Shh increased RA signalling in the corneal epithelium. As described above a severe reduction in corneal size was observed in the <i>PAX77<sup>+</sup></i> mouse: defective lens signalling as a result of Pax6 dosage was postulated to lead to this.  The lens is highly sensitive to Pax6 dosage.  Mouse/chick secondary chimeras were produced, through the grafting of <i>PAX77<sup>+</sup></i> and wild-type mouse lenses into a chicken eye, to investigate the role of altered Pax6 dosage in the lens on anterior eye development.  <i>PAX77<sup>+</sup></i> mouse/chick secondary chimeras, remarkably recapitulated the anterior eye phenotype seen in <i>PAX77<sup>+</sup></i> mice. This supports the role of altered Pax6 dosage in the lens resulting in the corneal abnormalities of the <i>PAX77<sup>+</sup></i> model.

Topical nanomedicine for the combination delivery of immuno-modulatory peptides for accelerated chronic wound healing and anti-bacterial activity

Fumakia, Miral 12 April 2016 (has links)
Wound treatment remains one of the most prevalent and economically burdensome healthcare concerns, often complicated by prolonged inflammation and bacterial infection, contributing to morbidity and mortality. Agents commonly used to treat chronic wound infections are limited due to their toxicity, multifactorial etiology of chronic wounds, deep skin infections, lack of sustained controlled delivery of drugs, and development of drug resistance. LL37 is an endogenous host defense peptide that has been shown to exhibit antimicrobial activity and is involved in the modulation of wound healing. Serpin A1 (A1) is a neutrophil elastase inhibitor and has been shown to demonstrate wound-healing property. Hence, our goal was to develop a topical combination nanomedicine for the controlled sustained delivery of LL37 and A1 that at precise combination ratios will significantly promote wound closure, reduce bacterial contamination, and enhance anti-inflammatory activity. We have successfully developed a solid lipid nanoparticle (SLN) formulation that can simultaneously deliver LL37 and A1 at specific ratios resulting in accelerated wound healing by promoting wound closure in BJ fibroblast cells and keratinocytes as well as synergistic enhancement of antibacterial activity against S. aureus and E. coli in comparison to LL37 or A1 alone. / May 2016

Mechanism of epithelialization of wounds in rabbits

Viziam, Chetty January 1965 (has links)
Thesis (M.A.)--Boston University / PLEASE NOTE: Boston University Libraries did not receive an Authorization To Manage form for this thesis or dissertation. It is therefore not openly accessible, though it may be available by request. If you are the author or principal advisor of this work and would like to request open access for it, please contact us at open-help@bu.edu. Thank you. / 2031-01-01


Gill, Barbara Pou January 1981 (has links)
Activities aimed at treating and/or monitoring the healing of wounds consume many nursing hours. However, most of the treatments used by nurses in caring for wounds are best classified as "reports of techniques" and are not based on research. Though no single initiator or promoter of wound healing has been isolated, epidermal growth factor (EGF), a naturally occurring polypeptide, has been reported to promote epidermal growth in vitro. In vivo, the application of EGF has been reported to increase proliferation and differentiation of epidermal tissue in newborn mice and to enhance the healing of corneal wounds in rabbits. Originally found in the submaxillary gland of male mice, EGF has now been found in the urine of humans. No reports have documented the in vivo effects of application of EGF to epidermal wounds of animals to determine if it will promote wound healing. The purposes of this study were to further elucidate the physiological and perhaps therapeutic function of EGF and to evaluate the feasibility in terms of availability, cost, and manageability of the pig as an animal model for controlled investigation of clinical nursing problems. Wound healing is a composite phenomenon of distinct yet interrelated phases: epithelialization, contraction, and fibrous healing. The reepithelialization of the wound is the result of migration of epidermal cells adjacent to the wound edge and differentiation of the new cells. Because of the risks and ethics involved in repeated biopsy of human wounds and the prematurity of use of EGF in humans, the specific problem this study was designed to answer is: Does the topical application of mouse epidermal growth factor (mEGF) increase the rate of healing of epidermal wounds in the domestic pig? An experimental design was used to test four hypotheses. Three of the hypotheses related to the process of wound healing were: (1) Topical application of 40 ng of mEGF will increase migration of keratinocytes over the wound. (2) Topical application of 40 ng of mEGF will increase the mitotic index. (3) Topical application of 40 ng of mEGF will increase the differentiation of keratinocytes over the wound. A fourth hypothesis, topical application of 40 ng of mEGF will increase the protein/DNA ratio in keratinocytes adjacent to and covering the wound, was tested since EGF is reported to be a potent mitogen increasing DNA synthesis and increasing intracellular protein. Using a modification of the Winter method, 82 wounds were created on the backs of ten young Yorkshire mix pigs in order to simulate the healing of two wounds over time. Mouse EGF was applied every two hours for six hours then every six hours for 48 hours (total of 54 hours) and 0.9 percent sodium chloride was applied to the control wounds in identical fashion. Tissue obtained from randomly assigned timed biopsises were examined histologically for the migration, mitosis, and differentiation of the keratinocytes. In addition, a portion of each biopsy was utilized for determination of protein/DNA ratio. Dependent t-tests of means showed no statistically significant differences between mEGF treated experimental and control wounds. Therefore, none of the hypotheses were supported. Graphic presentation of the data does indicate differences at specific points especially in the first 18-48 hours post-wounding. The pig was found to be a satisfactory model for controlled studies since the epidermal tissue is similar and the animals are relatively inexpensive, readily available, and become domesticated or relatively easy to handle in a short period of time.

Osteogenesis in the healing of the extraction wound /

Chau, Kai Kin. January 1968 (has links) (PDF)
Thesis (M.D.) -- University of Adelaide, Dept. of Dental Science, 1968. / Includes bibliography (28 p.).

Apical healing following apicoectomy with amalgam and gutta percha retrofilling materials

Marcotte, Lawrence Raymond. January 1972 (has links)
Thesis (M.S.)--University of Michigan, Ann Arbor, 1972. / Typescript (photocopy). Includes bibliographical references (leaves 41-43). Also issued in print.

In vivo epiboly formation following local application of epsilon-aminocaproic acid proposing to influence migrating epithelium to form eversion of its migrating edges following the extraction of molar teeth in rats. /

Zech, Ralph. January 1982 (has links)
Thesis (M.S.)--University of Michigan, 1982. / Typescript (photocopy). Includes bibliographical references (leaves 46-52). Also issued in print.

The role of nutrition during the early inflammatory stage of cutaneous wound healing

Lim, Yunsook. January 2003 (has links)
Thesis (Ph. D.)--Ohio State University, 2003. / Document formatted into pages; contains 140 p. Includes bibliographical references. Abstract available online via OhioLINK's ETD Center; full text release delayed at author's request until 2005 Dec. 20.

Page generated in 0.1202 seconds